Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Nonalcoholic steatohepatitis (NASH) is a condition which can progress to cirrhosis and hepatocellular carcinoma. Markers for NASH diagnosis are still lacking. We performed a comprehensive lipidomic analysis on human liver biopsies including normal liver, nonalcoholic fatty liver and NASH. Random forests-based machine learning approach allowed characterizing a signature of 32 lipids discriminating NASH with 100% sensitivity and specificity. Furthermore, we validated this signature in an independent group of NASH patients. Then, metabolism dysregulations were investigated in both patients and murine models. Alterations of elongase and desaturase activities were observed along the fatty acid synthesis pathway. The decreased activity of the desaturase FADS1 appeared as a bottleneck, leading upstream to an accumulation of fatty acids and downstream to a deficiency of long-chain fatty acids resulting to impaired phospholipid synthesis. In NASH, mass spectrometry imaging on tissue section revealed the spreading into the hepatic parenchyma of selectively accumulated fatty acids. Such lipids constituted a highly toxic mixture to human hepatocytes. In conclusion, this study characterized a specific and sensitive lipid signature of NASH and positioned FADS1 as a significant player in accumulating toxic lipids during NASH progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These data were confirmed by Chiappini et al.,98 who showed a significant reduction in PC, PE and SM in MASH.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · cited 4×
“defined by the presence of steatosis, ballooning of hepatocytes, Mallory’s bodies and lobular inflammation with infiltrated macrophages and leukocytes on liver histology 8,9 .”
InfluentialMembrane lipids: where they are and how they behave
van Meer, G., Voelker, D. R., & Feigenson, G. W. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2330 · Cited by 7,157
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling
Svetnik, V., Liaw, A., Tong, C., Culberson, J. C., Sheridan, R. P., & Feuston, B. P. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034160g · Cited by 3,573
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Cited by
Items 101–200 of 259
Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics
Sessa, A. D., Riccio, S., Pirozzi, E., Verde, M., Passaro, A. P., Umano, G. R., Guarino, S., del Giudice, E. M., & Marzuillo, P. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i25.3815 · Cited by 20
Jiang, L.-P., & Sun, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1051807 · Cited by 18
Hasenour, C. M., Kennedy, A. J., Bednarski, T., Trenary, I. A., Eudy, B. J., da Silva, R. P., Boyd, K. L., & Young, J. D. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000183 · Cited by 18
Advanced technologies in genomic toxicology: Current trend and future directions
Capone, P., Chiarella, P., & Sisto, R. (2023) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2023.100444 · Cited by 23
Liver metabolism in human MASLD: A review of recent advancements using human tissue metabolomics
Flam, E. L., Haas, J. T., & Staels, B. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.119054 · Cited by 19
Chamulitrat, W., Jansakun, C., Li, H., & Liebisch, G. (2020) · Biomolecules · doi:10.3390/biom10091332 · Cited by 17
Gunasekar, S. K., Heebink, J., Carpenter, D. H., Kumar, A., Xie, L., Zhang, H., Schilling, J. D., & Sah, R. (2023) · JCI Insight · doi:10.1172/jci.insight.154940 · Cited by 20
Kalveram, L., Schunck, W., Rothe, M., Rudolph, B. D., Loddenkemper, C., Holzhütter, H., Henning, S., Bufler, P., Schulz, M., Meierhofer, D., et al. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102229 · Cited by 18
The effect of enterolactone on liver lipid precursors of inflammation
Berk, K., Drygalski, K., Harasim‐Symbor, E., Charytoniuk, T., Iłowska, N., Łukaszuk, B., Chabowski, A., & Konstantynowicz-Nowicka, K. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.02.044 · Cited by 16
Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective
Huang, J., Sigon, G., Mullish, B. H., Wang, D., Sharma, R., Manousou, P., & Forlano, R. (2023) · Nutrients · doi:10.3390/nu15081992 · Cited by 16
Cuomo, G., Iandoli, C., Galiero, R., Caturano, A., Vico, C. D., Perretta, D., Adamo, P. V., Ferrara, R., Rinaldi, L., Romano, C. P., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13101766 · Cited by 17
Liu, J., Wu, H., Zhang, Y., Hu, C., Zhen, D., Fu, P., & He, Y. (2023) · Nutrients · doi:10.3390/nu15214573 · Cited by 15
HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson’s Disease
Zhi, Y., Sun, Y., Jiao, Y., Chen, P., Wu, Z., Liu, C., Su, J., Zhou, J., Shang, D., Niu, J., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.754185 · Cited by 16
Zhang, C.-Y., Liu, S., Sui, Y., & Yang, M. J. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i11.113756 · Cited by 15
Duparc, T., Gore, E., Combes, G., Beuzelin, D., Silva, J. P. D., Bouguetoch, V., Marqués, M.-A., Velazquez, A., Viguerie, N., Tavernier, G., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.175623 · Cited by 15
Rein‐Fischboeck, L., Haberl, E. M., Pohl, R., Feder, S., Liebisch, G., Krautbauer, S., & Buechler, C. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1114-4 · Cited by 15
Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults: A Cross‐Sectional Study
Mann, J. P., Jenkins, B., Furse, S., Snowden, S. G., Alisi, A., Draijer, L. G., Karnebeek, K., Kelly, D. A., Koot, B. G. P., Mosca, A., et al. (2022) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003418 · Cited by 15
Latorre, J., Díaz-Trelles, R., Comas, F., Gavaldà‐Navarro, A., Milbank, E., Dragano, N. R. V., Morón‐Ros, S., Mukthavaram, R., Ortega, F. J., Castells‐Nobau, A., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.08.003 · Cited by 16
Oridonin restores hepatic lipid homeostasis in an LXRα-ATGL/EPT1 axis-dependent manner
Chen, Y., Jiang, H., Zhan, Z., Lu, J., Gu, T., Yu, P., Liang, W., Zhang, X., Zhong, S., & Tang, L. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.08.010 · Cited by 14
Govaere, O., Petersen, S. K., Martínez-López, N., Wouters, J., Haele, M. V., Mancina, R. M., Jamialahmadi, O., Bilkei‐Gorzo, O., Lassen, P. B., Darlay, R., et al. (2020) · Journal of Hepatology · doi:10.1016/s0168-8278(20)30598-5 · Cited by 14
The Polymethoxyflavone Sudachitin Modulates the Circadian Clock and Improves Liver Physiology
Mawatari, K., Koike, N., Nohara, K., Wirianto, M., Uebanso, T., Shimohata, T., Shikishima, Y., Miura, H., Yoshitaka, N. I. I., Burish, M. J., et al. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200270 · Cited by 13
Badal, B. D., Fagan, A., Tate, V. V., Mousel, T., Gallagher, M. L., Puri, P., Davis, B., Miller, J., Sikaroodi, M., Gillevet, P. M., et al. (2024) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000707 · Cited by 16
Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro
Shatta, M. A., El-Derany, M. O., Gibriel, A. A., & EL-Mesallamy, H. O. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04619-6 · Cited by 14
Enhancing Hepatic MBOAT7 Expression in Mice With Nonalcoholic Steatohepatitis
Sharpe, M. C., Pyles, K. D., Hallcox, T., Kamm, D. R., Piechowski, M., Fisk, B. A., Albert, C. J., Carpenter, D. H., Ulmasov, B., Ford, D. A., et al. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.02.004 · Cited by 13
Lamantia, V., Bissonnette, S., Provost, V., Devaux, M., Cyr, Y., Daneault, C., Rosiers, C. D., & Faraj, M. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy238 · Cited by 17
Anari, M., Karimkhanloo, H., Nie, S., Li, D., Fidelito, G., Bayliss, J. A., Keenan, S. N., Slavin, J., Lin, S., Cheng, Z., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115007 · Cited by 14
Peng, K., Barlow, C. K., Kammoun, H. L., Mellett, N. A., Weir, J. M., Murphy, A. J., Febbraio, M. A., & Meikle, P. J. (2021) · Metabolites · doi:10.3390/metabo11030188 · Cited by 12
Aragón‐Herrera, A., Otero-Santiago, M., Anido‐Varela, L., Moraña‐Fernández, S., Campos‐Toimil, M., García‐Caballero, T., Barral, L., Tarazón, E., Roselló‐Lletí, E., Portolés, M., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.827033 · Cited by 12
Barboza, T. K., Susta, L., Linden, A. Z., Gardhouse, S. M., & Beaufrère, H. (2023) · PLoS ONE · doi:10.1371/journal.pone.0274060 · Cited by 12
Loh, C., Kuo, W., Lin, S., Shih, C.-Y., Lin, P., Situmorang, J. H., & Huang, C. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116557 · Cited by 12
Hou, C., Huang, M., Wang, P., Zhang, Q., Wang, G., & Gao, S. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.141442 · Cited by 12
Palomurto, S., Virtanen, K. A., Kärjä, V. J., Schwab, U., Kamińska, D., Käkelä, P., Pihlajamäki, J., & Männistö, V. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf346 · Cited by 13
Ramos‐Molina, B., Castellano‐Castillo, D., Pastor, Ó., Ocaña-Wilhelmi, L., Fernández‐García, D., Romero‐Gómez, M., Cardona, F., & Tinahones, F. J. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3612-2 · Cited by 11
Nagumalli, S. K., Willett, R. A., de Conti, A., Tryndyak, V., Avigan, M., da Costa, G. G., Beland, F. A., Rusyn, I., & Pogribny, I. P. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109108 · Cited by 11
Alterations of Lipid Profile in Livers with Impaired Lipophagy
Jonas, W., Schwerbel, K., Zellner, L., Jähnert, M., Gottmann, P., & Schürmann, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911863 · Cited by 11
Repin1 deficiency in liver tissue alleviates NAFLD progression in mice
Abshagen, K., Mense, L., Fischer, F., Liebig, M., Schaeper, U., Navarro, G., Glass, A. S., Frank, M., Klöting, N., & Vollmar, B. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2018.11.003 · Cited by 11
Mouskeftara, T., Kalopitas, G., Liapikos, T., Arvanitakis, K., Theocharidou, E., Germanidis, G. S., & Gika, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313067 · Cited by 11
Nutrigenomics of fat-soluble vitamins and micronutrients in hepatocyte lipotoxicity and MASLD
Migni, A., Bartolini, D., Ceccarini, M. R., Galli, C., Cavaliere, G., Garetto, S., Lucci, J., & Galli, F. (2026) · Progress in Lipid Research · doi:10.1016/j.plipres.2026.101380 · Cited by 10
Luo, H., Zhao, M., Feng, X., Gao, X., Hong, M., Liu, M., Li, Y., Liu, W., Liu, Y., Yu, C., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13469 · Cited by 11
Mazi, T. A., Borkowski, K., Fiehn, O., Bowlus, C. L., Sarkar, S., Matsukuma, K. E., Ali, M. R., Kieffer, D. A., Wan, Y. Y., Stanhope, K. L., et al. (2022) · Metabolites · doi:10.3390/metabo12020192 · Cited by 11
Sodum, N., Rao, V., Cheruku, S. P., Kumar, G., Sankhe, R., Kishore, A., Kumar, N., & Rao, C. M. (2022) · 3 Biotech · doi:10.1007/s13205-022-03192-5 · Cited by 10
Gunn, P. J., Pramfalk, C., Millar, V., Cornfield, T., Hutchinson, M., Johnson, E. M., Nagarajan, S. R., Troncoso‐Rey, P., Mithen, R. F., Pinnick, K. E., et al. (2020) · Physiological Reports · doi:10.14814/phy2.14482 · Cited by 12
Relaxin has beneficial effects on liver lipidome and metabolic enzymes
Aragón‐Herrera, A., Feijóo‐Bandín, S., Moraña‐Fernández, S., Anido‐Varela, L., Roselló‐Lletí, E., Portolés, M., Tarazón, E., Lage, R., Moscoso, I., Barral, L., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002620rr · Cited by 10
Willis, S. A., Malaikah, S., Bawden, S. J., Sherry, A. P., Sargeant, J. A., Coull, N. A., Bradley, C. R., Rowlands, A., Naim, I., Ennequin, G., et al. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15755 · Cited by 9
Zhu, Z., Chen, Y., Qin, X., Liu, S., Wang, J., & Ren, H. (2023) · Smart Medicine · doi:10.1002/smmd.20220029 · Cited by 10
Wang, X., Wu, L., Tao, J., Ye, H., Wang, J., Gao, R., & Liu, W. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-30306-0 · Cited by 9
Cheng, Z., & Montgomery, M. K. (2025) · Clinical Science · doi:10.1042/cs20257631 · Cited by 10
Chowdhury, R. R., Grosso, M., Gadara, D. C., Spáčil, Z., Vidová, V., Sovadinová, I., & Babica, P. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111046 · Cited by 9
Sourianarayanane, A., Brydges, C. R., & McCullough, A. J. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102402 · Cited by 9
Kytikovа, O. Y., Novgorodtseva, T. P., Denisenko, Y., & Kovalevskiy, D. A. (2020) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2020-30-2-15-25 · Cited by 10
Yan, J., Liu, Q., Tang, Q., Zhang, J., Jing, X., Xia, Y., Xu, Y., Li, J., Li, Y., & He, J. (2022) · The FASEB Journal · doi:10.1096/fj.202101975r · Cited by 9
Estévez‐Vázquez, O., Benedé‐Ubieto, R., Guo, F., Gómez‐Santos, B., Aspichueta, P., Reißing, J., Bruns, T., Sanz‐García, C., Sydor, S., Bechmann, L. P., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9101289 · Cited by 9
Lin, Y., Fang, Q., Xue, Y., Fu, S.-N., Hu, C., Huang, F., Wang, M., Qiao, X., Yin, X., Zeng, Y.-C., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116145 · Cited by 9
Taiwo, A., Merrill, R. A., Wendt, L. H., Pape, D. J., Thakkar, H., Maschek, J. A., Cox, J. E., Summers, S. A., Chaurasia, B., Pothireddy, N., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1500242 · Cited by 9
Antunes, G. C., Cunha, C. V. A., Oharomari, L. K., Vieira, R. F. L., Fanti, M., Rios, T. D. S., de Mattis, L. R. C., Macêdo, A. P. A., da Silva, A. S. R., Ropelle, E. R., et al. (2025) · The Journal of Physiology · doi:10.1113/jp287681 · Cited by 10
NMR microsystem for label-free characterization of 3D nanoliter microtissues
Grisi, M., Conley, G. M., Rodriguez, K. J., Riva, E., Egli, L., Moritz, W., Lichtenberg, J., Brügger, J., & Boero, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-75480-0 · Cited by 8
Antunes, M. M., Godoy, G., Curi, R., Visentainer, J. V., & Bazotte, R. B. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0107 · Cited by 8
Wu, H.-C., Hsieh, Y.-R., Wang, W., Chang, C.-W., Chang, I., Chen, C., Chang, C., Chang, C., Kao, W., & Huang, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113730 · Cited by 8
Feng, S., Wang, S.-J., Guo, L., Ma, P.-P., Ye, X., Pan, M., Hang, B., Mao, J., Snijders, A. M., Lu, Y., et al. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i5.898 · Cited by 8
Yu, Z., Fan, L., Tai, F., Zhang, L., Zhang, X., & Chen, Y. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250042 · Cited by 7
Jesus, D. F. D., Kimura, T., Gupta, M. K., & Kulkarni, R. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.06.001 · Cited by 7
Chiang, Y.-P., Li, Z., He, M., Jones, Q., Pan, M., Han, X., & Jiang, X. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105162 · Cited by 7
Castellanos‐Tapia, L., Tejero, M. E., Salas‐Silva, S., Nieves, A. S., Escobedo‐Calvario, A., & Gómez-Quiroz, L. E. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.06.005 · Cited by 7
Willett, R. A., Tryndyak, V., Hanks, J. M. H., Elkins, L., Nagumalli, S. K., Avigan, M., Ross, S. A., da Costa, G. G., Beland, F. A., Rusyn, I., et al. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.117046 · Cited by 7
Ghooray, D. T., Xu, M., Shi, H., McClain, C. J., & Song, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094836 · Cited by 6
Sowton, A. P., Holzner, L. M. W., Krause, F. N., Baxter, R. M., Mocciaro, G., Krzyzanska, D., Minnion, M., O’Brien, K. A., Harrop, M. C., Darwin, P. M., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00256.2024 · Cited by 7
Alam, N., Ding, X., Fu, Y., Jia, L., Ali, S. M., & Liu, E. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00190.2024 · Cited by 7
Jo, S. H., Lee, E. Y., Lee, S. B., Ha, K. B., & Chung, C. H. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156323 · Cited by 6
Alfadda, A. A., Almaghamsi, A. M., Sherbeeni, S. M., Alqutub, A. N., Aldosary, A. S., Isnani, A. C., Al‐Daghri, N. M., Taylor-Robinson, S. D., & Gul, R. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1030661 · Cited by 6
Seo, H.-S., Kim, H.-G., Joo, H.-E., Kwon, J., & Cho, J.-H. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120292 · Cited by 9
Tillander, V., Holmer, M., Hagström, H., Petersson, S., Brismar, T. B., Stal, P. I., & Lindqvist, C. (2024) · British Journal Of Nutrition · doi:10.1017/s0007114524001673 · Cited by 5
Gašperšič, J., Kastelic, M., Novak, U., & Likozar, B. (2018) · Acta chimica slovenica · doi:10.17344/acsi.2018.4591 · Cited by 5
Rosso, N., Stephenson, A. M., Giraudi, P. J., & Tiribelli, C. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-4723 · Cited by 5
Choline-deficient High-fat Diet-induced Steatohepatitis in BALB/c Mice
Nababan, S. H. H., Khairunissa, S. T., Erfan, E., Nafrialdi, N., Krisnuhoni, E., Hasan, I., & Gani, R. A. (2021) · Molecular and Cellular Biomedical Sciences · doi:10.21705/mcbs.v5i2.193 · Cited by 6
Kartsoli, S., Kostara, C. E., Papathanasiou, A. I., Tsimihodimos, V., Bairaktari, E. T., & Christodoulou, D. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136148 · Cited by 4
Lee, J., Kim, S., Ju, Y., Seo, M., Kim, H., Shin, J.-H., Na, Y., Kwon, Y., & Hwang, G. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118798 · Cited by 4
Iwasaki, S., Shirouchi, B., Okumura, M., Higuchi, M., Mitsuta, S., & YANAGITA, T. (2025) · ACS Nutrition Science · doi:10.1021/acsnutrsci.5c00023 · Cited by 4
Mazi, T. A., Shibata, N. M., Sarode, G. V., & Medici, V. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159446 · Cited by 7
Essential Oils for the Treatment and Management of Nonalcoholic Fatty Liver Disease (NAFLD)
Kim, T., Mijan, M. A., Lee, J., Yun, J., Chung, J. H., Son, S. M., & Kwon, R. J. (2024) · Natural Product Communications · doi:10.1177/1934578x241250248 · Cited by 4
EQLC-EC: An Efficient Voting Classifier for 1D Mass Spectrometry Data Classification
Guo, L., Wang, Y., Liu, Z., Zhang, F., Zhang, W., & Xiong, X. (2025) · Electronics · doi:10.3390/electronics14050968 · Cited by 4
Yang, Y., Jiao, L., Huang, Y., Shang, H., Li, E., Chang, H., Cui, H., & Wan, Y. (2025) · Environmental Health Perspectives · doi:10.1289/ehp15435 · Cited by 4
Régnier, M., Polizzi, A., Fougeray, T., Fougerat, A., Perrier, P., Anderson, K. E., Lippi, Y., Smati, S., Lukowicz, C., Lasserre, F., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003112 · Cited by 4
Self-citationLi, P., Sun, Z., Chen, X., Shao, Q., & Wu, H. (2025) · Metabolomics · doi:10.1007/s11306-025-02292-6 · Cited by 4
Key genes involved in nonalcoholic steatohepatitis improvement after bariatric surgery
Chen, X., Deng, S., Sun, Y., Bai, Y., Wang, Y., & Yang, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1338889 · Cited by 5
No Difference in Liver Damage Induced by Isocaloric Fructose or Glucose in Mice with a High-Fat Diet
Hsu, W., Lee, M.-H., Lii, C., & Peng, C. (2024) · Nutrients · doi:10.3390/nu16203571 · Cited by 4
A machine-learning approach for nonalcoholic steatohepatitis susceptibility estimation
Ghadiri, F., Husseini, A. A., & Öztaş, O. (2022) · Indian Journal of Gastroenterology · doi:10.1007/s12664-022-01263-2 · Cited by 4
Mechanisms of non-alcoholic fatty liver disease development in normal-weight individuals
Muriel, P., Cardoso-Lezama, I., Vargas-Pozada, E. E., & Ramos‐Tovar, E. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002530 · Cited by 4
Modern concepts on pathogenetic mechanisms of liver fibrosis
Александровна, Е. Н., Александровна, Г. В., & Goryacheva, L. G. (2023) · Journal Infectology · doi:10.22625/2072-6732-2023-15-1-16-24 · Cited by 4
Hepatocyte‐specific Selenoi deficiency predisposes mice to hepatic steatosis and obesity
Huang, X., Li, T., Yang, S., Zhu, K., Wang, L., Dong, Y., & Huang, J. (2024) · The FASEB Journal · doi:10.1096/fj.202400575rr · Cited by 4
Makri, E. S., Mouskeftara, T., Gika, H., Xanthopoulos, K., Makri, E., Mavrommatis-Parasidis, P., Tsingotjidou, A., Cheva, A., Goulas, A., & Pοlyzos, S. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199273 · Cited by 3
Virseda‐Berdices, A., Requena, B., Berenguer, J., Gónzalez-García, J., González-Riaño, C., Díez, C., Hontañón, V., Muñoz-García, P., Fernández‐Rodríguez, A., Barbas, C., et al. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102981 · Cited by 3
Dong, L., Lin, S., Slavin, J., Gunnam, S., Cheng, Z., Nie, S., Leeming, M. G., Williamson, N. A., & Montgomery, M. K. (2025) · Diabetes · doi:10.2337/db25-0588 · Cited by 3
Zhu, W., Zheng, Q., Xu, X., Xia, Y., Xu, X., Tu, H., Yu, Y., Ying, W., Xie, J., Sheng, G., et al. (2025) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2025.00406 · Cited by 7
Benhammou, J. N., Sinnett-Smith, J., Pisegna, J. R., & Rozengurt, E. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2022.07.017 · Cited by 4
Semertzidis, A., Mouskeftara, T., Gika, H., Pousinis, P., Makedou, K., Goulas, A., Kountouras, J., & Pοlyzos, S. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133798 · Cited by 3
Coilly, A., Desterke, C., Kaščáková, S., Chiappini, F., Samuel, D., Vibert, É., Guettier, C., & Naour, F. L. (2024) · Laboratory Investigation · doi:10.1016/j.labinv.2024.102110 · Cited by 2
Self-citationLu, C.-H., Hsieh, Y.-R., Huang, S.-Y., Wang, W., Chang, C.-W., Panunggal, B., Chang, I., Chen, C.-L., Chang, C.-C., & Kao, W. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08450-y · Cited by 2
Yang, F., Sun, X., Jiang, K., Zhang, M., & Sun, C. (2026) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70129 · Cited by 2
Moral, K., Koçak, E., Kablan, S. E., Nemutlu, E., Şendur, H. N., Cerit, M. N., Yalçın, M. M., Bilican, G., Cindoruk, M., Karakan, T., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-44786-w · Cited by 2
Membrane remodelling for increased methanol tolerance in Komagataella phaffii
Wang, S. Q., Yang, L., Li, Z. Y., Ye, H., Teng, F., Yang, J., Ye, C., Fan, D., & Han, S. (2026) · Nature Synthesis · doi:10.1038/s44160-026-01092-7 · Cited by 3
Metadata
- Authors
- Chiappini, F., Coilly, A., Kadar, H., Gual, P., Tran, A., Desterke, C., Samuel, D., Duclos-Vallée, J.-C., Touboul, D., Bertrand-Michel, J., Brunelle, A., Guettier, C., & Le Naour, F.
- Affiliations
- Université Paris-Sud (FR)
- Inserm (FR)
- Corresponding author
- Chiappini, Franck
- ORCID
- Venue
- Scientific Reports
- Published
- 2017-04-24
- Volume
- 7
- Issue
- 1
- Pages
- 46658-46658
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5402394
- OpenAlex
- W2609371482
- Cited by
- 246
- References
- 71
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 35 · 2023: 37 · 2022: 27 · 2021: 36 · 2020: 28 · 2019: 19 · 2018: 14 · 2017: 2
- FWCI
- 13.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-11-INBS, ANR-10, ANR-10-LABX, ANR-10-LABX-0033, ANR-11-INBS-0010)
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale (SPF20111223621)
- Centre National de la Recherche Scientifique (ANR-11-INBS-0010)
- Centre Hospitalier Universitaire de Nice
- Université Paris-Sud
- Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- nonalcoholic steatohepatitis, lipidomics, lipid signatures, FADS1, fatty acid desaturase, fatty acid synthesis, fatty acid accumulation, phospholipid synthesis, hepatocyte cytotoxicity, non-alcoholic fatty liver disease, liver biopsy, mass spectrometry imaging, metabolic dysfunction, NASH diagnosis
- MeSH terms
- Fatty Acid Elongases, Delta-5 Fatty Acid Desaturase, Acetyltransferases, Adult, Animals, Cells, Cultured, Fatty Acids, Female, Carcinoma, Hepatocellular, Humans, Lipids, Liver Cirrhosis, Liver Neoplasms, Male, Mice, Inbred C57BL, Middle Aged, Disease Progression, Hepatocytes, Fatty Acid Desaturases, Lipid Metabolism, Metabolomics, Hep G2 Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.